Cyclo Therapeutics, Inc. Profile Avatar - Palmy Investing

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment …

Drug Manufacturers - Specialty & Generic
US, Gainesville [HQ]

Investor Relations

Could not find a transcript